- Home
- KALV vs SNDA Comparison
KALV vs SNDA Comparison
Compare KALV & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- SNDA
- Stock Information
- Founded
- KALV N/A
- SNDA 1990
- Country
- KALV United States
- SNDA United States
- Employees
- KALV N/A
- SNDA N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- SNDA Hospital/Nursing Management
- Sector
- KALV Health Care
- SNDA Health Care
- Exchange
- KALV Nasdaq
- SNDA Nasdaq
- Market Cap
- KALV 563.1M
- SNDA 462.3M
- IPO Year
- KALV N/A
- SNDA 1997
- Fundamental
- Price
- KALV $12.00
- SNDA $21.40
- Analyst Decision
- KALV Strong Buy
- SNDA Hold
- Analyst Count
- KALV 8
- SNDA 1
- Target Price
- KALV $24.83
- SNDA $25.00
- AVG Volume (30 Days)
- KALV 729.1K
- SNDA 29.9K
- Earning Date
- KALV 03-12-2025
- SNDA 05-09-2025
- Dividend Yield
- KALV N/A
- SNDA N/A
- EPS Growth
- KALV N/A
- SNDA N/A
- EPS
- KALV N/A
- SNDA N/A
- Revenue
- KALV N/A
- SNDA $271,230,000.00
- Revenue This Year
- KALV N/A
- SNDA $22.33
- Revenue Next Year
- KALV N/A
- SNDA $6.31
- P/E Ratio
- KALV N/A
- SNDA N/A
- Revenue Growth
- KALV N/A
- SNDA 15.80
- 52 Week Low
- KALV $7.30
- SNDA $19.34
- 52 Week High
- KALV $15.50
- SNDA $34.19
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- SNDA 43.16
- Support Level
- KALV $11.42
- SNDA $21.19
- Resistance Level
- KALV $12.35
- SNDA $22.44
- Average True Range (ATR)
- KALV 0.96
- SNDA 1.29
- MACD
- KALV 0.04
- SNDA 0.02
- Stochastic Oscillator
- KALV 88.74
- SNDA 47.69
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.